NCT06395558 intErnet-based iNterventions FOR Cardiac arrEst suRvivors
| NCT ID | NCT06395558 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Azienda Usl di Bologna |
| Condition | Cognitive Impairment |
| Study Type | INTERVENTIONAL |
| Enrollment | 106 participants |
| Start Date | 2024-08-05 |
| Primary Completion | 2027-08-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 106 participants in total. It began in 2024-08-05 with a primary completion date of 2027-08-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized clinical trial will test whether an internet-based lifestyle intervention administered through a web app can foster Health Related Quality of Life in patients who survived an out-of-hospital cardiac arrest and suffer from these symptoms
Eligibility Criteria
Inclusion Criteria: * Hospital discharge after out-of-hospital cardiac arrest with Cerebral Performance Category 1 or 2 * Informed consent for participation in the study * Native Italian speaker or adequate understanding of the Italian language * Adequate ability to use the web to guarantee access to the contents Exclusion Criteria: * Previous cognitive dysfunction * Previous psychiatric disease * Previous episode of out-of-hospital cardiac arrest
Contact & Investigator
Lorenzo Gamberini, MD
PRINCIPAL INVESTIGATOR
Azienda USL Bologna
Frequently Asked Questions
Who can join the NCT06395558 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Cognitive Impairment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06395558 currently recruiting?
Yes, NCT06395558 is actively recruiting participants. Contact the research team at gamberini6@ausl.bologna.it for enrollment information.
Where is the NCT06395558 trial being conducted?
This trial is being conducted at Bologna, Italy, Imola, Italy.
Who is sponsoring the NCT06395558 clinical trial?
NCT06395558 is sponsored by Azienda Usl di Bologna. The principal investigator is Lorenzo Gamberini, MD at Azienda USL Bologna. The trial plans to enroll 106 participants.